Kronos Bio Stock Market Value
| KRON Stock | USD 1.03 0.08 8.42% |
| Symbol | Kronos |
Kronos Bio Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Kronos Bio. If investors know Kronos will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Kronos Bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.74) | Revenue Per Share 0.143 | Quarterly Revenue Growth 0.442 | Return On Assets (0.28) | Return On Equity (0.63) |
The market value of Kronos Bio is measured differently than its book value, which is the value of Kronos that is recorded on the company's balance sheet. Investors also form their own opinion of Kronos Bio's value that differs from its market value or its book value, called intrinsic value, which is Kronos Bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Kronos Bio's market value can be influenced by many factors that don't directly affect Kronos Bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Kronos Bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if Kronos Bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Kronos Bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Kronos Bio 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Kronos Bio's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Kronos Bio.
| 08/24/2024 |
| 09/23/2024 |
If you would invest 0.00 in Kronos Bio on August 24, 2024 and sell it all today you would earn a total of 0.00 from holding Kronos Bio or generate 0.0% return on investment in Kronos Bio over 30 days. Kronos Bio is related to or competes with Cyclerion Therapeutics, Larimar Therapeutics, Addex Therapeutics, Achilles Therapeutics, NextCure, CytomX Therapeutics, and Spero Therapeutics. Kronos Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of novel cancer t... More
Kronos Bio Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Kronos Bio's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Kronos Bio upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 4.53 | |||
| Information Ratio | 0.0059 | |||
| Maximum Drawdown | 35.99 | |||
| Value At Risk | (6.48) | |||
| Potential Upside | 8.42 |
Kronos Bio Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Kronos Bio's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Kronos Bio's standard deviation. In reality, there are many statistical measures that can use Kronos Bio historical prices to predict the future Kronos Bio's volatility.| Risk Adjusted Performance | 0.0326 | |||
| Jensen Alpha | (0.04) | |||
| Total Risk Alpha | (0.59) | |||
| Sortino Ratio | 0.0068 | |||
| Treynor Ratio | 0.088 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Kronos Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Kronos Bio Backtested Returns
Kronos Bio appears to be very risky, given 3 months investment horizon. Kronos Bio has Sharpe Ratio of 0.0486, which conveys that the firm had a 0.0486% return per unit of risk over the last 3 months. We have found thirty technical indicators for Kronos Bio, which you can use to evaluate the volatility of the firm. Please exercise Kronos Bio's Mean Deviation of 3.25, risk adjusted performance of 0.0326, and Downside Deviation of 4.53 to check out if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Kronos Bio holds a performance score of 3. The company secures a Beta (Market Risk) of 1.65, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Kronos Bio will likely underperform. Please check Kronos Bio's rate of daily change, period momentum indicator, as well as the relationship between the expected short fall and maximum drawdown , to make a quick decision on whether Kronos Bio's current price movements will revert.
Auto-correlation | -0.29 |
Weak reverse predictability
Kronos Bio has weak reverse predictability. Overlapping area represents the amount of predictability between Kronos Bio time series from 24th of August 2024 to 8th of September 2024 and 8th of September 2024 to 23rd of September 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Kronos Bio price movement. The serial correlation of -0.29 indicates that nearly 29.0% of current Kronos Bio price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.29 | |
| Spearman Rank Test | 0.05 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Kronos Bio lagged returns against current returns
Autocorrelation, which is Kronos Bio stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Kronos Bio's stock expected returns. We can calculate the autocorrelation of Kronos Bio returns to help us make a trade decision. For example, suppose you find that Kronos Bio has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Kronos Bio regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Kronos Bio stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Kronos Bio stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Kronos Bio stock over time.
Current vs Lagged Prices |
| Timeline |
Kronos Bio Lagged Returns
When evaluating Kronos Bio's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Kronos Bio stock have on its future price. Kronos Bio autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Kronos Bio autocorrelation shows the relationship between Kronos Bio stock current value and its past values and can show if there is a momentum factor associated with investing in Kronos Bio.
Regressed Prices |
| Timeline |
Pair Trading with Kronos Bio
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kronos Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kronos Bio will appreciate offsetting losses from the drop in the long position's value.Moving together with Kronos Stock
Moving against Kronos Stock
| 0.7 | XGN | Exagen Inc | PairCorr |
| 0.61 | REGN | Regeneron Pharmaceuticals | PairCorr |
| 0.59 | SLS | Sellas Life Sciences | PairCorr |
| 0.57 | SNY | Sanofi ADR | PairCorr |
| 0.55 | BIAFW | BioAffinity Technologies | PairCorr |
The ability to find closely correlated positions to Kronos Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kronos Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kronos Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kronos Bio to buy it.
The correlation of Kronos Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kronos Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kronos Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kronos Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Information and Resources on Investing in Kronos Stock
When determining whether Kronos Bio offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Kronos Bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Kronos Bio Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Kronos Bio Stock:Check out Kronos Bio Correlation, Kronos Bio Volatility and Kronos Bio Alpha and Beta module to complement your research on Kronos Bio. To learn how to invest in Kronos Stock, please use our How to Invest in Kronos Bio guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Kronos Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.